Sun Pharmaceutical Industries Limited is a multinational pharmaceutical company from India. It is renowned for its manufactures in pharmaceutical formulations and active pharmaceutical ingredients primarily in India and the United States. It covers the branches in Dermatology, Ophthalmology, and Onco-Dermatology.
It holds the largest pharmaceutical ranking by market capitalization and the fourth largest specialty generic company globally with its presence in Specialty, Generics and consumer healthcare products.
Sun Pharmaceutical Industries Limited has been included in the S and P Global Sustainability Yearbook 2024, for its groundbreaking achievements in and unwavering commitment to sustainability and business practices. The company strives at an integration of environmental, social and governance principles and is constantly dedicated to delivering sustainable outcomes for all stakeholders. The company’s ethos, framework and the operational strategies aim at a sustainable future.
The S and P Global Corporate Sustainability Assessment CSA for 2023 assessed over 9400 companies for the yearbook 2024 and 739 companies qualified for the inclusion along with Sun Pharmaceutical Industries. The company exhibits a vibrant strategy in environmental initiatives, shoulders social responsibility and is well integrated in governance framework, crossing boundaries and establishing an active stakeholder engagement, regulatory compliance and future outlook.
Effective environmental initiative towards environmental sustainability by Sun Pharmaceutical Industries include a tapestry of initiatives. Reducing carbon footprint by implementing energy- efficient technologies, optimizing manufacturing processes to minimize waste generation, and investing in renewable energy resources have paved a new beginning to embrace eco-sensitive manufacturing. Furthermore, the company has set strategies and green goals to reduce water consumption by improving water management practices across its operations. An integration of environmental considerations into its business strategy by Sun Pharmaceutical Industries not only attempts to promote ecology but also envisions for a resilient and green future.
Sun Pharma has set its priorities in social responsibility by focusing on key societal issues such as access to healthcare, education, and community development. The company’s initiatives in healthcare infrastructure improvement particularly to uplift the undeserved communities through medical provisions marks a difference in its approach to societal reformation. It also actively collaborates with NGO’S, government agencies and healthcare professionals.
Sun Pharma has constantly achieved effective corporate governance thus establishing trust among its stakeholders and ensured long-term business sustainability. Robust governance mechanisms to uphold ethical standards, transparency, and accountability across its operations have been the key sources for success in governance. Key components like independent board of directors, adopting best practices in risk management and compliance, and enhancing stakeholder engagement through ongoing communication and reporting have brought laurels for the company.
The recognition of a wide range of stakeholders, including investors, employees, customers, suppliers, and communities has been the hallmark of Sun Pharma. The company builds trust, fosters collaboration, and addresses stakeholder concerns in a timely and reflective manner. It also demonstrates an effective commitment to regulatory compliance by adopting quality standards, safety protocols, and ethical guidelines. The company envisions a future where sustainability forms the thrust of its operations.
In conclusion, Sun Pharmaceutical Industries Limited’s inclusion in the S and P Global Sustainability Yearbook marks its achievement in leadership, commitment and global competitiveness. It has well depicted the corporate sustainability roles and has set an example worldwide.
Written by: William Santosh | Edited by: Nandni Ranpara
